EspaƱa
India
Italia
ėķėƼźµ
ę„ę¬
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
EspaƱa
India
Italia
ėķėƼźµ
ę„ę¬
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
FSD Pharma
HUGE
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.152200
0.01
10.21%
At Close: -
$0.150000
-0.0022
-1.45%
After Hours: 4:46 PM EDT
15 minutes delayed
Get Report
Comment
FSD Pharma (HUGE) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for FSD Pharma (NASDAQ:HUGE) Stock
FSD Pharma Stock (NASDAQ: HUGE)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, July 09, 2024
'GOP Congressional Committee Approves Bill To...
Benzinga Newsdesk
Friday, June 28, 2024
FSD Pharma Wins Court Judgment Against Former...
Benzinga Newsdesk
Thursday, June 13, 2024
FSD Pharma shares are trading higher after th...
Benzinga Newsdesk
FSD Pharma Enters Exclusive Option Agreement ...
Benzinga Newsdesk
Tuesday, May 28, 2024
FSD Pharma Submits Clinical Trial Protocol To...
Benzinga Newsdesk
Thursday, May 16, 2024
Shares of cannabis stocks are trading higher ...
Benzinga Newsdesk
President Biden Posts On X "Too Many Lives Ha...
Benzinga Newsdesk
'Justice Department Poised To Post Plans For ...
Benzinga Newsdesk
Friday, May 10, 2024
'DEA Appears To Question Marijuana's Medical ...
Benzinga Newsdesk
Monday, May 06, 2024
Newsweek Reporter Kevin Sabet Says On X "I Ca...
Benzinga Newsdesk
"Florida GOP Formally Opposes Marijuana Legal...
Benzinga Newsdesk
Wednesday, May 01, 2024
'Declassifying Cannabis Still Leaves Pot Stoc...
Benzinga Newsdesk
Tuesday, April 30, 2024
DEA Moving To Reclassify Marijuana As Less Da...
Benzinga Newsdesk
FSD Pharma Signs Agreement With Applied Scien...
Benzinga Newsdesk
Monday, April 29, 2024
Watching Shares Of Marijuana Stocks; Traders ...
Benzinga Newsdesk
Thursday, April 25, 2024
FSD Pharma Provides Update From Celly Nu's Pa...
Benzinga Newsdesk
Monday, April 22, 2024
FSD Pharma Provides Update On Celly Nu's Anti...
Benzinga Newsdesk
Friday, April 19, 2024
'Cannabis Seizures At Checkpoints By U.S.-Mex...
Benzinga Newsdesk
Wednesday, April 17, 2024
'Senator Presses Attorney General Garland On ...
Benzinga Newsdesk
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
Lara Goldstein
FSD Pharma Says It Has Initiated Investigatio...
Benzinga Newsdesk
Monday, April 15, 2024
'Marijuana Companies Ask Federal Court To Set...
Benzinga Newsdesk
Thursday, April 11, 2024
'FDA Head Says There's 'No Reason For DEA To ...
Benzinga Newsdesk
Saturday, March 30, 2024
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Lara Goldstein
Wednesday, March 27, 2024
'GOP Senators Tell DEA To Reject Marijuana Re...
Benzinga Newsdesk
FSD Pharma Signs Agreement With iNGENu CRO To...
Benzinga Newsdesk
Saturday, March 16, 2024
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
Lara Goldstein
Monday, March 11, 2024
'DEA Officials Reportedly At Odds With Biden ...
Benzinga Newsdesk
Fsd Pharma Announced Submission Of Clinical T...
Benzinga Newsdesk
Tuesday, March 05, 2024
FSD Pharma Highlights Presentation Of Lucid-2...
Benzinga Newsdesk
Monday, March 04, 2024
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
Lara Goldstein
Monday, February 26, 2024
Too Drunk? This Beverage Could Sober You Up Quickly
Lara Goldstein
FSD Pharma Signs Agreement With Ingenu CRO To Conduct A Clinical Trial To Determine The Safety And Efficacy Effects Of Its Proprietary Blend Beverage "unbuzzd"
Happy Mohamed
Wednesday, January 17, 2024
Safety Shot Responds To FSD Pharma's Unauthor...
Benzinga Newsdesk
Thursday, January 11, 2024
GBB Drink Lab. Inc Announce That A Federal Co...
Benzinga Newsdesk
Wednesday, December 27, 2023
Psyched: Biden Approves Psychedelics Trials, RFK, Australia's First Legal Dedicated Clinic & More
Lara Goldstein
Friday, December 22, 2023
Inebriation Remedy And Breakthrough MS Treatment: Meet FSD Pharma
Lara Goldstein
Friday, November 24, 2023
Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More
Lara Goldstein
Friday, November 17, 2023
FSD Pharma Announces Distribution Date As Nov...
Benzinga Newsdesk
Monday, November 13, 2023
Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More
Lara Goldstein
Tuesday, November 07, 2023
FSD Pharma Provides Update On Proposed Divide...
Benzinga Newsdesk
Psyched: DEA's Denial Overruled, Fed Psychedelics Change, Psilocybin For Depression, States Reform & More
Lara Goldstein
Monday, October 30, 2023
Psyched: Cybin's Center Stage In Novel Psychedelics, Musk & Ramaswamy, Britney's Memoir And More
Lara Goldstein
Sunday, October 22, 2023
Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted
Lara Goldstein
Monday, October 16, 2023
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
Lara Goldstein
Friday, October 06, 2023
Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More
Lara Goldstein
Thursday, October 05, 2023
Ontario Court Upholds Canadian Biopharmaceutical Win Over Former CEO In C$2.8M Dispute
Joana Scopel
Monday, October 02, 2023
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
Lara Goldstein
Tuesday, September 26, 2023
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
Lara Goldstein
Monday, September 18, 2023
Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More
Lara Goldstein
Show More